Rasuvo: payments to doctors
Payments that named Rasuvo as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $117K
- Providers
- 862
- Transactions
- 2,913
- Average per transaction
- $40
The per-transaction average — $40 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 862 providers the average total is $136, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Medexus Pharma, Inc. | $116,996 | 100.0% |